{"count": 168, "results": [{"_id": "36187122", "pmid": 36187122, "pmcid": "PMC9524196", "title": "Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials", "journal": "Front Endocrinol (Lausanne)", "authors": ["Nabrdalik K", "Skonieczna-Żydecka K", "Irlik K", "Hendel M", "Kwiendacz H", "Łoniewski I", "Januszkiewicz K", "Gumprecht J", "Lip GYH"], "date": "2022-09-14T00:00:00Z", "doi": "10.3389/fendo.2022.975912", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "975912", "score": 50281.734, "text_hl": "Regression for RR toward @<m>DISEASE_Diarrhea</m> @DISEASE_MESH:D003967 @@@diarrhea@@@ by type of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Nabrdalik K, Skonieczna-Żydecka K, Irlik K, Hendel M, Kwiendacz H, Łoniewski I, Januszkiewicz K, Gumprecht J, Lip GYH. Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials Front Endocrinol (Lausanne). 2022;13():975912. PMID: 36187122", "BibTeX": "@article{36187122, title={Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials}, author={Nabrdalik K and Skonieczna-Żydecka K and Irlik K and Hendel M and Kwiendacz H and Łoniewski I and Januszkiewicz K and Gumprecht J and Lip GYH}, journal={Front Endocrinol (Lausanne)}, volume={13}, pages={975912}}"}}, {"_id": "32213489", "pmid": 32213489, "pmcid": "PMC7170402", "title": "Mouse model of metformin-induced diarrhea", "journal": "BMJ Open Diabetes Res Care", "authors": ["Takemori H", "Hamamoto A", "Isogawa K", "Ito M", "Takagi M", "Morino H", "Miura T", "Oshida K", "Shibata T"], "date": "2020-03-01T00:00:00Z", "doi": "10.1136/bmjdrc-2019-000898", "meta_date_publication": "2020 Mar", "meta_volume": "8", "meta_issue": "1", "meta_pages": "", "score": 50275.27, "text_hl": "@SPECIES_10090 @@@Mouse@@@ model of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-induced @<m>DISEASE_Diarrhea</m> @DISEASE_MESH:D003967 @@@diarrhea@@@", "citations": {"NLM": "Takemori H, Hamamoto A, Isogawa K, Ito M, Takagi M, Morino H, Miura T, Oshida K, Shibata T. Mouse model of metformin-induced diarrhea BMJ Open Diabetes Res Care. 2020 Mar;8(1):. PMID: 32213489", "BibTeX": "@article{32213489, title={Mouse model of metformin-induced diarrhea}, author={Takemori H and Hamamoto A and Isogawa K and Ito M and Takagi M and Morino H and Miura T and Oshida K and Shibata T}, journal={BMJ Open Diabetes Res Care}, volume={8}, number={1}}"}}, {"_id": "37590844", "pmid": 37590844, "title": "Case Report: Late-Onset Metformin-Associated Diarrhea.", "journal": "Am Fam Physician", "authors": ["Flaherty RJ"], "date": "2023-08-01T00:00:00Z", "meta_date_publication": "2023 Aug", "meta_volume": "108", "meta_issue": "2", "meta_pages": "Online", "score": 50272.81, "text_hl": "Case Report: Late-Onset @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-Associated @<m>DISEASE_Diarrhea</m> @DISEASE_MESH:D003967 @@@Diarrhea@@@.", "citations": {"NLM": "Flaherty RJ. Case Report: Late-Onset Metformin-Associated Diarrhea. Am Fam Physician. 2023 Aug;108(2):Online. PMID: 37590844", "BibTeX": "@article{37590844, title={Case Report: Late-Onset Metformin-Associated Diarrhea.}, author={Flaherty RJ}, journal={Am Fam Physician}, volume={108}, number={2}, pages={Online}}"}}, {"_id": "40607156", "pmid": 40607156, "title": "Metformin induces diarrhea in mice under over-eating conditions.", "journal": "Diabetol Int", "authors": ["Chikama K", "Takemroi H", "Mizoguchi M", "Furukawa S", "Terada K", "Ito M", "Hirano H", "Miura T", "Doi K", "Horiya M", "Kato T", "Yabe D", "Shibata T"], "date": "2025-06-05T00:00:00Z", "doi": "10.1007/s13340-025-00822-0", "meta_date_publication": "2025 Jul", "meta_volume": "16", "meta_issue": "3", "meta_pages": "568-579", "score": 50272.656, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ induces @<m>DISEASE_Diarrhea</m> @DISEASE_MESH:D003967 @@@diarrhea@@@ in @SPECIES_10090 @@@mice@@@ under over-eating conditions.", "citations": {"NLM": "Chikama K, Takemroi H, Mizoguchi M, Furukawa S, Terada K, Ito M, Hirano H, Miura T, Doi K, Horiya M, Kato T, Yabe D, Shibata T. Metformin induces diarrhea in mice under over-eating conditions. Diabetol Int. 2025 Jul;16(3):568-579. PMID: 40607156", "BibTeX": "@article{40607156, title={Metformin induces diarrhea in mice under over-eating conditions.}, author={Chikama K and Takemroi H and Mizoguchi M and Furukawa S and Terada K and Ito M and Hirano H and Miura T and Doi K and Horiya M and Kato T and Yabe D and Shibata T}, journal={Diabetol Int}, volume={16}, number={3}, pages={568-579}}"}}, {"_id": "36077758", "pmid": 36077758, "pmcid": "PMC9454846", "title": "Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies", "journal": "Cancers (Basel)", "authors": ["Ohno M", "Kitanaka C", "Miyakita Y", "Tanaka S", "Sonoda Y", "Mishima K", "Ishikawa E", "Takahashi M", "Yanagisawa S", "Ohashi K", "Nagane M", "Narita Y"], "date": "2022-08-30T00:00:00Z", "doi": "10.3390/cancers14174222", "meta_date_publication": "2022 Aug 30", "meta_volume": "14", "meta_issue": "17", "meta_pages": "", "score": 50267.844, "text_hl": "One @SPECIES_9606 @@@patient@@@ (JP-02-001) in the Level 2 cohort manifested grade 2 @<m>DISEASE_Diarrhea</m> @DISEASE_MESH:D003967 @@@diarrhea@@@, @DISEASE_Feeding_and_Eating_Disorders @DISEASE_MESH:D001068 @@@appetite loss@@@, and @DISEASE_Abdominal_Pain @DISEASE_MESH:D015746 @@@abdominal pain@@@ during treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@ Step 2 dose of 1500 mg/day before Cycle 1 of @CHEMICAL_Temozolomide @CHEMICAL_MESH:D000077204 @@@TMZ@@@. ", "citations": {"NLM": "Ohno M, Kitanaka C, Miyakita Y, Tanaka S, Sonoda Y, Mishima K, Ishikawa E, Takahashi M, Yanagisawa S, Ohashi K, Nagane M, Narita Y. Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies Cancers (Basel). 2022 Aug 30;14(17):. PMID: 36077758", "BibTeX": "@article{36077758, title={Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies}, author={Ohno M and Kitanaka C and Miyakita Y and Tanaka S and Sonoda Y and Mishima K and Ishikawa E and Takahashi M and Yanagisawa S and Ohashi K and Nagane M and Narita Y}, journal={Cancers (Basel)}, volume={14}, number={17}}"}}, {"_id": "37816179", "pmid": 37816179, "title": "Compounding Metformin for Use in Functional Medicine.", "journal": "Int J Pharm Compd", "authors": ["Desai S", "Thompson T"], "date": "2023-09-01T00:00:00Z", "meta_date_publication": "2023 Sep-Oct", "meta_volume": "27", "meta_issue": "5", "meta_pages": "362-366", "score": 50258.277, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ can cause issues with the gastrointestinal tract and result in @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Abdominal_Pain @DISEASE_MESH:D015746 @@@abdominal pain@@@, @<m>DISEASE_Diarrhea</m> @DISEASE_MESH:D003967 @@@diarrhea@@@, @DISEASE_Gas_bloat_syndrome @DISEASE_MESH:C535647 @@@bloating@@@, or @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@. ", "citations": {"NLM": "Desai S, Thompson T. Compounding Metformin for Use in Functional Medicine. Int J Pharm Compd. 2023 Sep-Oct;27(5):362-366. PMID: 37816179", "BibTeX": "@article{37816179, title={Compounding Metformin for Use in Functional Medicine.}, author={Desai S and Thompson T}, journal={Int J Pharm Compd}, volume={27}, number={5}, pages={362-366}}"}}, {"_id": "35602825", "pmid": 35602825, "pmcid": "PMC9117863", "title": "Metformin-Associated Lactic Acidosis: A Case Report and Review", "journal": "Cureus", "authors": ["Ashraf S", "Upreti P", "Karki S", "Khan M", "Nasr R"], "date": "2022-04-17T00:00:00Z", "doi": "10.7759/cureus.24220", "meta_date_publication": "2022 Apr", "meta_volume": "14", "meta_issue": "4", "meta_pages": "e24220", "score": 50257.53, "text_hl": "While the @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@gastrointestinal@@@ side effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ such as @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@, @<m>DISEASE_Diarrhea</m> @DISEASE_MESH:D003967 @@@diarrhea@@@, and @DISEASE_Heartburn @DISEASE_MESH:D006356 @@@heartburn@@@ are quite common, one dangerous side effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@, is extensively discussed yet rarely reported. ", "citations": {"NLM": "Ashraf S, Upreti P, Karki S, Khan M, Nasr R. Metformin-Associated Lactic Acidosis: A Case Report and Review Cureus. 2022 Apr;14(4):e24220. PMID: 35602825", "BibTeX": "@article{35602825, title={Metformin-Associated Lactic Acidosis: A Case Report and Review}, author={Ashraf S and Upreti P and Karki S and Khan M and Nasr R}, journal={Cureus}, volume={14}, number={4}, pages={e24220}}"}}, {"_id": "34244196", "pmid": 34244196, "title": "Metformin-associated lactic acidosis.", "journal": "BMJ Case Rep", "authors": ["Fadden EJ", "Longley C", "Mahambrey T"], "date": "2021-07-08T00:00:00Z", "doi": "10.1136/bcr-2020-239154", "meta_date_publication": "2021 Jul 8", "meta_volume": "14", "meta_issue": "7", "meta_pages": "", "score": 50256.49, "text_hl": "A 58-year-old female with known @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ continued to take her usual medications, including @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, an ACE inhibitor and a non-steroidal anti-inflammatory drug, while suffering from @<m>DISEASE_Diarrhea</m> @DISEASE_MESH:D003967 @@@diarrhoea@@@ and @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@. ", "citations": {"NLM": "Fadden EJ, Longley C, Mahambrey T. Metformin-associated lactic acidosis. BMJ Case Rep. 2021 Jul 8;14(7):. PMID: 34244196", "BibTeX": "@article{34244196, title={Metformin-associated lactic acidosis.}, author={Fadden EJ and Longley C and Mahambrey T}, journal={BMJ Case Rep}, volume={14}, number={7}}"}}, {"_id": "35431313", "pmid": 35431313, "pmcid": "PMC9026230", "title": "Transient Complete Blindness Due to Metformin-Associated Lactic Acidosis (MALA) Reversed with Hemodialysis", "journal": "Am J Case Rep", "authors": ["Rueda Prada L", "Knopps L", "Dumic I", "Barusya C", "Subramanian A", "Charokopos A", "Zurob AS"], "date": "2022-04-18T00:00:00Z", "doi": "10.12659/AJCR.935730", "meta_date_publication": "2022 Apr 18", "meta_volume": "23", "meta_issue": "", "meta_pages": "e935730", "score": 50254.766, "text_hl": "We hypothesize that her initial @<m>DISEASE_Diarrhea</m> @DISEASE_MESH:D003967 @@@diarrhea@@@ was an adverse effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or it was a self-limiting viral @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@gastrointestinal infection@@@. ", "citations": {"NLM": "Rueda Prada L, Knopps L, Dumic I, Barusya C, Subramanian A, Charokopos A, Zurob AS. Transient Complete Blindness Due to Metformin-Associated Lactic Acidosis (MALA) Reversed with Hemodialysis Am J Case Rep. 2022 Apr 18;23():e935730. PMID: 35431313", "BibTeX": "@article{35431313, title={Transient Complete Blindness Due to Metformin-Associated Lactic Acidosis (MALA) Reversed with Hemodialysis}, author={Rueda Prada L and Knopps L and Dumic I and Barusya C and Subramanian A and Charokopos A and Zurob AS}, journal={Am J Case Rep}, volume={23}, pages={e935730}}"}}, {"_id": "37635987", "pmid": 37635987, "pmcid": "PMC10449574", "title": "Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis", "journal": "Front Endocrinol (Lausanne)", "authors": ["Zeng H", "Zhang Y", "Huang S", "Wu J", "Ren W", "Zhou L", "Huang L", "Ye Y"], "date": "2023-08-10T00:00:00Z", "doi": "10.3389/fendo.2023.1223768", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1223768", "score": 50253.69, "text_hl": "Maliha et al. demonstrated that the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was related to a high incidence of side-effects, particularly @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@gastrointestinal (GI) reactions@@@ such as @DISEASE_Postoperative_Nausea_and_Vomiting @DISEASE_MESH:D020250 @@@nausea, vomiting@@@, @<m>DISEASE_Diarrhea</m> @DISEASE_MESH:D003967 @@@diarrhea@@@, and @DISEASE_Abdominal_Pain @DISEASE_MESH:D015746 @@@abdominal pain@@@. ", "citations": {"NLM": "Zeng H, Zhang Y, Huang S, Wu J, Ren W, Zhou L, Huang L, Ye Y. Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis Front Endocrinol (Lausanne). 2023;14():1223768. PMID: 37635987", "BibTeX": "@article{37635987, title={Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis}, author={Zeng H and Zhang Y and Huang S and Wu J and Ren W and Zhou L and Huang L and Ye Y}, journal={Front Endocrinol (Lausanne)}, volume={14}, pages={1223768}}"}}]}